TY - JOUR
T1 - Twenty years and counting
T2 - Epidemiology of an outbreak of isoniazid-resistant tuberculosis in England and wales, 1995 to 2014
AU - Smith, C. M.
AU - Trienekens, S. C.M.
AU - Anderson, Charlotte
AU - Lalor, M. K.
AU - Brown, T.
AU - Story, A.
AU - Fry, H.
AU - Hayward, A. C.
AU - Maguire, Helen
N1 - Publisher Copyright:
© 2017, European Centre for Disease Prevention and Control (ECDC). All Rights Reserved.
PY - 2017/2/23
Y1 - 2017/2/23
N2 - An outbreak of isoniazid-resistant tuberculosis first identified in London has now been ongoing for 20 years, making it the largest drug-resistant outbreak of tuberculosis documented to date worldwide. We identified culture-confirmed cases with indistinguishable molecular strain types and extracted demographic, clinical, microbiological and social risk factor data from surveillance systems. We summarised changes over time and used kernel-density estimation and k-function analysis to assess geographic clustering. From 1995 to 2014, 508 cases were reported, with a declining trend in recent years. Overall, 70% were male (n = 360), 60% born in the United Kingdom (n = 306), 39% white (n = 199), and 26% black Caribbean (n = 134). Median age increased from 25 years in the first 5 years to 42 in the last 5. Approximately two thirds of cases reported social risk factors: 45% drug use (n = 227), 37% prison link (n = 189), 25% homelessness (n = 125) and 13% alcohol dependence (n = 64). Treatment was completed at 12 months by 52% of cases (n = 206), and was significantly lower for those with social risk factors (p < 0.05), but increased over time for all patients (p < 0.05). The outbreak remained focused in north London throughout. Control of this outbreak requires continued efforts to prevent and treat further active cases through targeted screening and enhanced case management.
AB - An outbreak of isoniazid-resistant tuberculosis first identified in London has now been ongoing for 20 years, making it the largest drug-resistant outbreak of tuberculosis documented to date worldwide. We identified culture-confirmed cases with indistinguishable molecular strain types and extracted demographic, clinical, microbiological and social risk factor data from surveillance systems. We summarised changes over time and used kernel-density estimation and k-function analysis to assess geographic clustering. From 1995 to 2014, 508 cases were reported, with a declining trend in recent years. Overall, 70% were male (n = 360), 60% born in the United Kingdom (n = 306), 39% white (n = 199), and 26% black Caribbean (n = 134). Median age increased from 25 years in the first 5 years to 42 in the last 5. Approximately two thirds of cases reported social risk factors: 45% drug use (n = 227), 37% prison link (n = 189), 25% homelessness (n = 125) and 13% alcohol dependence (n = 64). Treatment was completed at 12 months by 52% of cases (n = 206), and was significantly lower for those with social risk factors (p < 0.05), but increased over time for all patients (p < 0.05). The outbreak remained focused in north London throughout. Control of this outbreak requires continued efforts to prevent and treat further active cases through targeted screening and enhanced case management.
UR - http://www.scopus.com/inward/record.url?scp=85014622865&partnerID=8YFLogxK
U2 - 10.2807/1560-7917.ES.2017.22.8.30467
DO - 10.2807/1560-7917.ES.2017.22.8.30467
M3 - Article
C2 - 28251890
AN - SCOPUS:85014622865
SN - 1025-496X
VL - 22
JO - Eurosurveillance
JF - Eurosurveillance
IS - 8
ER -